Mr John C Gross, MD | |
2841 Lexington Ave, Ashland, KY 41101-3009 | |
(606) 324-2451 | |
(606) 324-7123 |
Full Name | Mr John C Gross |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 34 Years |
Location | 2841 Lexington Ave, Ashland, Kentucky |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245209550 | NPI | - | NPPES |
0160061 | Medicaid | OH | |
64280894 | Medicaid | KY | |
180021151 | Other | KY | MEDICARE RAILROAD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 28089 (Kentucky) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Tri-state Ophthalmology Associates Psc | 9931157179 | 5 |
Tri-state Ophthalmology Associates Psc | 9931157179 | 5 |
News Archive
Peregrine Pharmaceuticals, Inc. has announced that updated preliminary data from the first stage of its Phase II trial evaluating bavituximab in combination with docetaxel showed that 10 of 14 (71%) evaluable breast cancer patients achieved an objective tumor response according to RECIST criteria.
Merck, known as MSD outside the United States and Canada, and Intercell AG (VSE: ICLL) today announced that following a detailed analysis of the data from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus (S. aureus) infection, the independent Data Monitoring Committee (DMC) has unanimously recommended termination of the study.
A once a year injection of an osteoporosis drug has been found to reduce the number of new hip fractures for older people and also saves lives.
Dr. Kristin Sohl, a pediatrician at the University of Missouri Thompson Center for Autism and Neurodevelopmental Disorders, will expand the growing ECHO Autism program, which launched in March, to an additional 10 sites.
› Verified 5 days ago
Entity Name | Tri-state Ophthalmology Associates Psc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245261833 PECOS PAC ID: 9931157179 Enrollment ID: O20050105000134 |
News Archive
Peregrine Pharmaceuticals, Inc. has announced that updated preliminary data from the first stage of its Phase II trial evaluating bavituximab in combination with docetaxel showed that 10 of 14 (71%) evaluable breast cancer patients achieved an objective tumor response according to RECIST criteria.
Merck, known as MSD outside the United States and Canada, and Intercell AG (VSE: ICLL) today announced that following a detailed analysis of the data from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus (S. aureus) infection, the independent Data Monitoring Committee (DMC) has unanimously recommended termination of the study.
A once a year injection of an osteoporosis drug has been found to reduce the number of new hip fractures for older people and also saves lives.
Dr. Kristin Sohl, a pediatrician at the University of Missouri Thompson Center for Autism and Neurodevelopmental Disorders, will expand the growing ECHO Autism program, which launched in March, to an additional 10 sites.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Mr John C Gross, MD 2841 Lexington Ave, Ashland, KY 41101-3009 Ph: (606) 324-2451 | Mr John C Gross, MD 2841 Lexington Ave, Ashland, KY 41101-3009 Ph: (606) 324-2451 |
News Archive
Peregrine Pharmaceuticals, Inc. has announced that updated preliminary data from the first stage of its Phase II trial evaluating bavituximab in combination with docetaxel showed that 10 of 14 (71%) evaluable breast cancer patients achieved an objective tumor response according to RECIST criteria.
Merck, known as MSD outside the United States and Canada, and Intercell AG (VSE: ICLL) today announced that following a detailed analysis of the data from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus (S. aureus) infection, the independent Data Monitoring Committee (DMC) has unanimously recommended termination of the study.
A once a year injection of an osteoporosis drug has been found to reduce the number of new hip fractures for older people and also saves lives.
Dr. Kristin Sohl, a pediatrician at the University of Missouri Thompson Center for Autism and Neurodevelopmental Disorders, will expand the growing ECHO Autism program, which launched in March, to an additional 10 sites.
› Verified 5 days ago
Mary Martha Reams, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 613 23rd St Ste 350, Ashland, KY 41101 Phone: 606-408-4600 Fax: 606-408-4605 | |
Joshua C Gross, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2841 Lexington Ave, Ashland, KY 41101 Phone: 606-324-2451 Fax: 606-324-7123 | |
Mr. Carter H Gussler, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2841 Lexington Ave, Ashland, KY 41101 Phone: 606-324-2451 Fax: 606-324-7123 | |
Cody A Williams, DO Ophthalmology Medicare: Medicare Enrolled Practice Location: 2841 Lexington Ave, Ashland, KY 41101 Phone: 606-324-2451 Fax: 606-324-7123 | |
Dr. Maurice J Oakley, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1901 Winchester Ave, Suite 102, Ashland, KY 41101 Phone: 606-329-2211 Fax: 606-324-9207 |